Biological Evaluation of 18F-FHTP as a Potential Dopamine D4 Receptor PET Imaging Agent
-
Graphical Abstract
-
Abstract
3-(4-18Ffluorobenzyl)-8-hydroxy-1, 2, 3, 4-tetrahydrochromeno3, 4-c pyridin-5-one (18F-FHTP) was in vitroand in vivoevaluated as a potential dopamine D4 receptor PET imaging agent. Through receptor binding assay, the Kiof FHTP were determined to be 2.9 nmol/L for D4.2 receptor, and to be greater than 3 000 and 5 800 nmol/L for D3 and D2 receptor, respectively. The lgP was measured to be 1.11 through octanol experiment. The regional biodistribution studies in rats were carried out through biological distribution and blocking biodistribution experiments. The biodistributions studies show that 18F-FHTP can penetrate through bloodbrain barrier and selectively accumulate in striatum, hypothalamus, frontal cortex, hippocampus, cerebellum, where the D4 receptor is reportedly located, and among organs, lung and kidney have higher uptakes than the others. Conclusively, in vitro and in vivo biological studies demonstrate that 18F-FHTP is a potential dopamine D4 receptor imaging agent.
-
-